NEW YORK CITY, NY / ACCESS Newswire / October 1, 2025 / NEW YORK, NY / ACCESS Newswire / October 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ACADIA Pharmaceuticals Inc. ("ACADIA") (NASDAQ:ACAD) concerning possible violations of federal securities laws.
On September 24, 2025, Acadia issued a press release "announcing top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients with hyperphagia in Prader-Willi syndrome (PWS)." The press release disclosed that the drug "did not demonstrate a statistically significant improvement over placebo on the study’s primary endpoint, change from baseline to Week 12 on the Hyperphagia Questionnaire for Clinical Trials (HQ-CT), nor was there separation from placebo on any secondary endpoint." Acadia’s Head of Research and Development stated that, "given these results, we do not intend to investigate intranasal carbetocin any further."
On this news, Acadia’s stock price fell $2.34 per share, or 9.92%, to close at $21.26 per share on September 24, 2025. To obtain additional information, go to:
https://zlk.com/pslra-1/acadia-lawsuit-submission-form?prid=170498&wire=1&utm_campaign=45
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212)363-7500.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212)363-7500
Fax: (212)363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP
View the original press release on ACCESS Newswire
COMTEX_469205837/2457/2025-10-01T19:00:19